Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota

被引:29
|
作者
Salminen, Antero [1 ]
机构
[1] Univ Eastern Finland, Inst Clin Med, Dept Neurol, POB 1627, Kuopio 70211, Finland
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2023年 / 101卷 / 03期
关键词
Aging; Hypoperfusion; Immunosuppression; Microbiome; Microflora; Uremic toxin; BLOOD-BRAIN-BARRIER; KYNURENINE PATHWAY METABOLISM; AMYLOID PRECURSOR PROTEIN; CHRONIC KIDNEY-DISEASE; CHAIN FATTY-ACIDS; NF-KAPPA-B; INDOXYL SULFATE; OXIDATIVE STRESS; ANGIOTENSIN-II; NITRIC-OXIDE;
D O I
10.1007/s00109-023-02289-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Gut microbiota in interaction with intestinal host tissues influences many brain functions and microbial dysbiosis has been linked with brain disorders, such as neuropsychiatric conditions and Alzheimer's disease (AD). l-tryptophan metabolites and short-chained fatty acids (SCFA) are major messengers in the microbiota-brain axis. Aryl hydrocarbon receptors (AhR) are main targets of tryptophan metabolites in brain microvessels which possess an enriched expression of AhR protein. The Ah receptor is an evolutionarily conserved, ligand-activated transcription factor which is not only a sensor of xenobiotic toxins but also a pleiotropic regulator of both developmental processes and age-related tissue degeneration. Major microbiota-produced tryptophan metabolites involve indole derivatives, e.g., indole 3-pyruvic acid, indole 3-acetaldehyde, and indoxyl sulfate, whereas indoleamine and tryptophan 2,3-dioxygenases (IDO/TDO) of intestine host cells activate the kynurenine (KYN) pathway generating KYN metabolites, many of which are activators of AhR signaling. Chronic kidney disease (CKD) increases the serum level of indoxyl sulfate which promotes AD pathogenesis, e.g., it disrupts integrity of blood-brain barrier (BBB) and impairs cognitive functions. Activation of AhR signaling disturbs vascular homeostasis in brain; (i) it controls blood flow via the renin-angiotensin system, (ii) it inactivates endothelial nitric oxide synthase (eNOS), thus impairing NO production and vasodilatation, and (iii) it induces oxidative stress, stimulates inflammation, promotes cellular senescence, and enhances calcification of vascular walls. All these alterations are evident in cerebral amyloid angiopathy (CAA) in AD pathology. Moreover, AhR signaling can disturb circadian regulation and probably affect glymphatic flow. It seems plausible that dysbiosis of gut microbiota impairs the integrity of BBB via the activation of AhR signaling and thus aggravates AD pathology.Key messagesDysbiosis of gut microbiota is associated with dementia and Alzheimer's disease.Tryptophan metabolites are major messengers from the gut host-microbiota to brain.Tryptophan metabolites activate aryl hydrocarbon receptor (AhR) signaling in brain.The expression of AhR protein is enriched in brain microvessels and blood-brain barrier.Tryptophan metabolites disturb brain vascular integrity via AhR signaling.Dysbiosis of gut microbiota promotes inflammation and AD pathology via AhR signaling.
引用
收藏
页码:201 / 222
页数:22
相关论文
共 50 条
  • [41] Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins
    Brito, Jessyca S.
    Borges, Natlaia A.
    Esgalhado, Marta
    Magliano, D'Angelo C.
    Soulage, Christophe O.
    Mafra, Denise
    NEPHRON, 2017, 137 (01) : 1 - 7
  • [42] Microbiota, Tryptophan and Aryl Hydrocarbon Receptors as the Target Triad in Parkinson's Disease-A Narrative Review
    Iwaniak, Paulina
    Owe-Larsson, Maja
    Urbanska, Ewa M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [43] Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice
    Xu, Xiuxiu
    Sun, Siyuan
    Liang, Ling
    Lou, Chenxi
    He, Qijin
    Ran, Maojuan
    Zhang, Lu
    Zhang, Jingyue
    Yan, Chen
    Yuan, Hengjie
    Zhou, Lu
    Chen, Xin
    Dai, Xin
    Wang, Bangmao
    Zhang, Jie
    Zhao, Jingwen
    FRONTIERS IN NUTRITION, 2021, 8
  • [44] Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies
    Shabbir, Umair
    Arshad, Muhammad Sajid
    Sameen, Aysha
    Oh, Deog-Hwan
    NUTRIENTS, 2021, 13 (02) : 1 - 23
  • [45] Correction: The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer’s Disease
    Anatoly V. Skalny
    Michael Aschner
    Abel Santamaria
    Tommaso Filippini
    Viktor A. Gritsenko
    Yousef Tizabi
    Feng Zhang
    Xiong Guo
    Joao B. T. Rocha
    Alexey A. Tinkov
    Molecular Neurobiology, 2025, 62 (2) : 1693 - 1693
  • [46] The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease
    Wiatrak, Benita
    Balon, Katarzyna
    Jawien, Paulina
    Bednarz, Dominika
    Jeskowiak, Izabela
    Szelag, Adam
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [47] Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer's Disease
    Naseer, Muhammad I.
    Bibi, Fehmida
    Alqahtani, Mohammed H.
    Chaudhary, Adeel G.
    Azhar, Esam I.
    Kamal, Mohammad A.
    Yasir, Muhammad
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) : 305 - 311
  • [48] The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment
    Varesi, Angelica
    Pierella, Elisa
    Romeo, Marcello
    Piccini, Gaia Bavestrello
    Alfano, Claudia
    Bjorklund, Geir
    Oppong, Abigail
    Ricevuti, Giovanni
    Esposito, Ciro
    Chirumbolo, Salvatore
    Pascale, Alessia
    NUTRIENTS, 2022, 14 (03)
  • [49] Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer's Disease: A Multivariable Mendelian Randomization Study
    Ning, Min
    An, Lina
    Dong, Liang
    Zhu, Ranran
    Hao, Jingjing
    Liu, Xueyuan
    Zhang, Yuanyuan
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 100 (01) : 229 - 237
  • [50] Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells
    Rosser, Elizabeth C.
    Piper, Christopher J. M.
    Matei, Diana E.
    Blair, Paul A.
    Rendeiro, Andre F.
    Orford, Michael
    Alber, Dagmar G.
    Krausgruber, Thomas
    Catalan, Diego
    Klein, Nigel
    Manson, Jessica J.
    Drozdov, Ignat
    Bock, Christoph
    Wedderburn, Lucy R.
    Eaton, Simon
    Mauri, Claudia
    CELL METABOLISM, 2020, 31 (04) : 837 - +